Integra LifeSciences Holdings Corp (IART) stock
IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)
Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –
Integra LifeSciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Integra LifeSciences's enterprise value was $865.60M on Nov 11, 2026, against $736.99M a year earlier. Over the last 5 years it ranged from $458.51M to $5.24B, with a median of $1.78B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $865.60M | +26.7% |
| 2025 | Dec 31, 2025 | $683.38M | -53.8% |
| 2024 | Dec 31, 2024 | $1.48B | -55.0% |
| 2023 | Dec 29, 2023 | $3.29B | -22.0% |
| 2022 | Dec 30, 2022 | $4.21B | -19.6% |
| 2021 | Dec 31, 2021 | $5.24B | +1.8% |
| 2020 | Dec 31, 2020 | $5.15B | +6.9% |
| 2019 | Dec 31, 2019 | $4.82B | +37.4% |
| 2018 | Dec 31, 2018 | $3.51B | +5.8% |
| 2017 | Dec 29, 2017 | $3.31B | -0.2% |
| 2016 | Dec 30, 2016 | $3.32B | +49.3% |
| 2015 | Dec 31, 2015 | $2.22B | +52.8% |
| 2014 | Dec 31, 2014 | $1.45B | +33.6% |
| 2013 | Dec 31, 2013 | $1.09B | +23.5% |
| 2012 | Dec 31, 2012 | $881.95M | +22.4% |
| 2011 | Dec 30, 2011 | $720.46M | -39.9% |
| 2010 | Dec 31, 2010 | $1.20B | +57.3% |
| 2009 | Dec 31, 2009 | $762.47M | – |
See a number that looks wrong?